Novo Nordisk executive reports high interest for once-daily, oral weight-loss pill

Novo Nordisk executive reports high interest for once-daily, oral weight-loss pill

Novo Nordisk launched an oral version of its GLP-1 injectable to US markets January 5...

Redirecting to full article...